MAZE (STOCKS)
Maze Therapeutics, Inc. Common Stock
$47.220000
-1.150000 (-2.38%)
Prev close: $48.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jason V. Coloma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,440.74M
- Employees
- 125
- P/E (TTM)
- -20.95
- P/B (TTM)
- 5.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $422.06M |
| Current Assets | $391.30M |
| Cash | $383.90M |
| Other Current Assets | $7.40M |
| Noncurrent Assets | $30.76M |
| Fixed Assets | $5.54M |
| Other Non-current Assets | $25.22M |
| Liabilities | $42.62M |
| Current Liabilities | $22.11M |
| Accounts Payable | $2.92M |
| Wages | $8.19M |
| Other Current Liabilities | $11.01M |
| Noncurrent Liabilities | $20.51M |
| Equity | $379.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $379.44M |
| Liabilities And Equity | $422.06M |